Arginine

Arginine

SCHEMBL9767853

N=C(N)NCCC[C@H](N)C(=O)O.O=C(C=Cc1cccs1)Nc1ccccc1C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.46
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
MAPT P10636 4/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 3/20 0.40
TRPM2 O94759 2/20 0.40
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
HPGD P15428 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
LTB4R Q15722 1/20 0.40
TRPA1 O75762 6/20 0.40
TRPM8 Q7Z2W7 4/20 0.40
KDM4E B2RXH2 3/20 0.39
POLB P06746 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL9768070 0.86 RAB9A (0.50) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL13854028 0.80 RAB9A (0.69) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL9767854 0.80 RAB9A (0.69) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL9768217 0.78 RAB9A (0.67) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL14250016 0.77 CYP2C9 (0.46) MAPTKMT2AMEN1HPGD
Arginine SCHEMBL4208935 0.73 ALDH1A1 (0.45) SMN1; SMN2NPC1MAPTHTTKMT2A
Arginine SCHEMBL4728793 0.73 OTC (0.40) HTTKMT2APOLBTDP1
Arginine SCHEMBL5606089 0.73 ALDH1A1 (0.45) SMN1; SMN2NPC1MAPTHTTKMT2A
Arginine SCHEMBL2485034 0.73 OTC (0.40) HTTKMT2APOLBTDP1
Arginine SCHEMBL29601459 0.73 HCAR2 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006548-A Hyaluronidase inhibitors, antiallergens, immunomodulators SAWAI PHARMACEUTICAL CO., LTD. (JP) 1991-04-09 US disclosed
EP-0153850-B1 ACRYLAMIDOBENZOIC ACID DERIVATIVES AND THEIR USE SAWAI PHARMACEUTICAL CO., LTD. (JP) 1989-09-13 EP disclosed
EP-0153850-A1 Acrylamidobenzoic acid derivatives and their use SAWAI PHARMACEUTICAL CO., LTD. (JP) 1985-09-04 EP disclosed